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Abstract: This study focuses on the design, fabrication, microstructural and property character-
ization, and biocompatibility evaluation of polypropylene (PP) reinforced with carbon nanofiber 
(CNF) and hydroxyapatite nanorod (HANR) fillers. The purpose is to develop advanced PP/
CNF–HANR hybrids with good mechanical behavior, thermal stability, and excellent biocompat-
ibility for use as craniofacial implants in orthopedics. Several material-examination techniques, 
including X-ray diffraction, Fourier-transform infrared spectroscopy, scanning electron micros-
copy, thermogravimetric analysis, differential scanning calorimetry, tensile tests, and impact 
measurement are used to characterize the microstructural, mechanical, and thermal properties of 
the hybrids. Furthermore, osteoblastic cell cultivation and colorimetric assay are also employed 
for assessing their viability on the composites. The CNF and HANR filler hybridization yields 
an improvement in Young’s modulus, impact strength, thermal stability, and biocompatibility 
of PP. The PP/2% CNF–20% HANR hybrid composite is found to exhibit the highest elastic 
modulus, tensile strength, thermal stability, and biocompatibility.
Keywords: nanocomposite, implant, cellular viability, mechanical behavior
Introduction
There has been growing interest amongst materials scientists, biomedical engineers, 
and surgeons in the use of novel biomaterials for the treatment of severe skeletal defects 
and injuries in recent years. Human bone defects can be caused by trauma, cancer, 
infection, and congenital abnormality. Autografts taken from the patient’s bones and 
allografts from cadavers are typically used for replacing bone-tissue defects. However, 
limited supply of autografts and the immunological rejection reaction of allografts are 
their main drawbacks. In this respect, artificial implants are considered as alternative 
materials for treating bone disease and trauma.
Metallic materials, such as Fe-based alloy (American Iron and Steel Institute 
316 stainless steel), Co-based alloy (60.6 wt% Co, 31.5 wt% Cr, 6.0 wt% Mo, 1.9 wt% 
residuals [Si, Mn and C]; Vitallium®), and Ti-based alloy (Ti–6 wt% Al–4 wt% V) are 
typically used as implants in orthopedics. However, metallic materials have many disad-
vantages for use as bone-replacement implants. Corrosion and wear are major concerns 
of the long-term performance of metallic prosthesis. Fe-based stainless alloy may suffer 
pitting corrosion upon exposure to human body fluid containing about 0.9% NaCl.1 
This is because chloride ion destroys passive film formed on stainless steel. Moreover, 
some metallic ions and wear debris released from metallic implants can cause allergy 
International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1300
liao et al
and infection.2–4 Aluminum ions released from the Ti–6 wt% 
Al–4 wt% V alloy can induce Alzheimer’s disease, while 
vanadium ions can modify enzyme activity of the cells. The 
toxicity of vanadium has driven the development of novel 
biomaterials for replacing Ti–6Al–4V. Furthermore, Young’s 
modulus of metallic implants is much higher than that of 
human cortical bone, leading to the so-called stress-shielding 
effect. Stress shielding is the inhomogeneous transfer of stress 
between the implant and bone. Young’s moduli of 316 stainless 
steel, CoCrMo alloy, and Ti–6Al–4V alloy are in the ranges 
of 205–210 GPa, 220–230 GPa, and 115 GPa respectively. 
They are much higher than Young’s modulus of human cortical 
bone, which ranges from 7 to 30 GPa.5
Bone tissue is a biocomposite with hydroxyapatite (HA) 
nanoplatelets dispersed in the collagen matrix. The HA 
mineral exhibits high hardness and excellent biocompat-
ibility, osteoconductivity, and bioactivity. The designed bio-
composites for load-bearing biomedical applications should 
combine the advantages of both components.6 However, 
synthetic HA collagen composites possess low mechani-
cal strength, and thus are typically used for biodegradable 
scaffolds in orthopedics.7,8 To enhance the mechanical per-
formance of biocomposites, nondegradable polymers, such 
as high-density polyethylene (HDPE), have been selected as 
the matrix of HA-reinforced PE composite (HAPEX™).9–11 
The incorporation of 40 vol% HA microparticles into HDPE 
results in a considerable increase in its elastic modulus. 
However, HAPEX with low tensile strength is mainly used 
for orbital floor prosthesis, middle ear implant, and maxil-
lofacial surgery. Furthermore, large HA particles with sizes 
of several micrometers often debond readily from the polymer 
matrix and fracture into small fragments during mechanical 
testing.12
Recent progress in nanotechnology has allowed the syn-
thesis of nanomaterials with excellent physical and mechani-
cal properties,13 as well as biocompatibility.14,15 For example, 
synthetic nanoscale HA strongly promotes the adhesion and 
proliferation of osteoblasts.16–18 Carbon nanotubes (CNTs) 
with exceptionally high Young’s modulus (about 1 TPa) 
and excellent electrical conductivity show good biocom-
patibility towards human cells like osteoblasts, myoblasts, 
and neurons.19–22 In this context, nano-HA and CNTs have 
been employed as reinforcing fillers for polymers in form-
ing functional composites for biomedical applications.23–32 
However, CNTs with coiled morphology disperse poorly 
in the polymeric matrix, especially at higher filler contents. 
This leads to inferior mechanical performance of the result-
ing composites. In contrast, carbon nanofibers (CNFs) with 
a straight feature can better disperse in the polymeric matrix 
of biocomposites. Other advantages of CNFs include lower 
production cost and good biocompatibility. In this regard, 
CNFs have been incorporated into polymers to form func-
tional composites for biomedical applications.33,34 CNFs 
are generally synthesized by the catalytic decomposition of 
hydrocarbons on transition metal catalysts, such as Fe, Co, 
and Cu nanoparticles, at high temperatures.35–37 Straight 
and helical CNFs can be selectively prepared by properly 
monitoring the reaction temperature, feed-gas composition, 
and the shape of metal nanoparticles. In the latter case, Jian 
et al reported that spherical Cu nanoparticles favor formation 
of straight CNFs, while polyhedral or facetted Cu catalysts 
yield helical CNFs.37
In a previous study, we prepared polypropylene (PP) 
composites with 5–20 wt% HA nanorods (HANRs).25 
The results showed that the addition of 20 wt% HANRs 
(6.67 vol%) to PP improves its mechanical performance and 
biocompatibility. PP exhibits excellent chemical resistance, 
durability, dimensional stability, and flexibility. PP exhibits 
higher fatigue resistance than HDPE, and thus can replace 
ductile HDPE for biomedical implants experiencing frequent 
cyclic stress. In this study, we investigated the influence of 
CNF additions on the structural, thermal, and mechanical 
behaviors of PP and PP/20 wt% HANR composites. In the 
latter case, low CNF loadings (0.5–2 wt%) were added to the 
PP/20 wt% HANR composite to yield hybrids with higher 
mechanical performance and biocompatibility. The aim was 
to develop polymer-composite implants with good biocom-
patibility for bone-defect repair and replacement, especially 
for craniofacial applications.
Materials and methods
Materials
PP (Moplen HP500N) was purchased from LyondellBasell 
Polymers (Saudi Arabia). CNFs of 50–200 nm (diameter) and 
0.5–20 µm (length) were obtained from Nanostructured and 
Amorphous Materials (Houston, TX, USA). HANRs were 
purchased from Nanjing Emperor Nano Materials (Nanjing, 
People’s Republic of China), with an average width of 20 nm 
and length of 120 nm.
Preparation of nanocomposites
Table 1 list the compositions of PP/CNF and PP/CNF–
HANR composites. The precursor materials of these com-
posites were first melt-extruded in a Brabender (Duisburg, 
 Germany) with blending temperature profiles of 215°C, 
230°C, 230°C, 220°C, 195°C, and 180°C at a rotation speed 
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of 40 rpm. The extrudates were pelletized and blended 
again in the Brabender. The obtained materials were granu-
lized again, dried, and subsequently injection-molded into 
rectangular plaques. Pure PP and PP/20% HANR nano-
composite were also fabricated under the same processing 
conditions.
characterization
X-ray diffraction (XRD) experiments were carried out with 
a Siemens (Munich, Germany) D500 diffractometer (Cu-Kα 
radiation) operating at 40 kV and 30 mA. Fourier-transform 
infrared (FTIR) spectra in the range of 400–4,000 cm−1 were 
recorded with a PerkinElmer (Waltham, MA, USA) spectrom-
eter (16PC). Morphological analysis of the composites was 
performed in a JEOL (Tokyo, Japan) field-emission scanning 
electron microscope (FE-SEM; JSM-7100F). The crystalli-
zation behavior of PP/CNF and PP/CNF–HANR nanocom-
posites was studied using a differential scanning calorimeter 
(DSC; model 2910; TA Instruments, New Castle, DE, USA) 
purged with nitrogen. The specimen was first scanned from 
room temperature to 200°C at 100°C/minute, then held for 
3 minutes to delete its previous thermal history, followed by 
cooling at 10°C/minute. Thermogravimetric experiments 
were performed with a TGA Q50 (TA Instruments) in a 
nitrogen atmosphere from 30°C to 550°C at 20°C/minute. 
The temperature at 5% weight loss (T
5%
) was determined 
from the weight loss-versus-temperature curves.
Tensile and notched impact specimens were prepared 
from injection-molded plaques. Tensile tests were per-
formed with an Instron Corporation (Norwood, MA, USA) 
tester (model 5567) at room temperature at 10 mm/minute 
based on the ASTM D638-08. The Izod impact tests were 
performed with an impact tester (CEAST model 6545; 
Instron) according to the ASTM D256-05. Both tensile 
and impact tests employed six specimens of each com-
posite material, and the average values were determined 
accordingly.
cell culture and proliferation
For the cell-culture experiment, the human osteoblast cell line 
Saos-2 was grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 10% fetal bovine serum and penicillin/ 
streptomycin. The samples were sterilized with 70% ethanol 
and rinsed with sterile phosphate-buffered saline (PBS). Then, 
100 µL medium containing 104 cells was seeded on sterile 
samples placed into the wells of a 96-well culture plate. The 
plate was put into an incubator at 37°C under a humidified 
atmosphere with 5% CO
2
 and 95% air. After cultivation for 48 
and 96 hours, respectively, the specimens were rinsed with PBS 
and treated with 10% formaldehyde. They were then dehydrated 
with a series of graded ethanol solutions, followed by critical 
point drying. The cellular constructs were sputter-coated with 
gold, and imaged in a scanning electron microscope (SEM).
The cell viability of samples was determined with 
a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. Samples placed in a 96-well plate 
were seeded with 100 µL suspension with 104 cells. This 
plate was put into an incubator at 37°C in a humidified 
atmosphere of 95% air and 5% CO
2
 for periods of 2, 4, 7, 
and 10 days. The DMEM was refreshed every 3 days. After 
the desired incubation period, sterile MTT solution of 10 µL 
was added to each well and kept for a further 4 hours to 
obtain insoluble formazan crystals. Finally, 100 µL of 10% 
sodium dodecyl sulfate 0.01 M HCl was added to each well 
to dissolve formazan crystals. The light absorbance in each 
well was determined at 570 nm using a multimode detector 
(DTX 880; Beckman Coulter, Pasadena, CA, USA), with a 
background correction at 640 nm. The well with 100 µL cell 
suspension and the well without cells (DMEM only) were 
employed as the positive and negative controls, respectively. 
The number of samples for each material in the tests was 
five, and the MTT assay tests were repeated at least twice. 
Data were reported as means and standard deviation.
Results and discussion
structural and morphological analyses
Figure 1 shows the XRD patterns of PP and PP-based 
composites. Pristine PP is characterized by diffrac-
tion peaks at 2θ =14.1°, 16.9°, 18.5°, 21.2°, and 21.8° 
associated with the (110), (040), (130), (111), and (041) 
reflections. The HANR peaks occur at 26.0°, 28.3°, 29.0° 
31.9°, 33.0°, and 34.2°, corresponding to the (002), (102), 
(210), (211), (112), and (300) planes. It can be seen that 
the incorporation of CNF and/or HANR nanofillers into 
the polymer matrix does not induce structural change 
of the PP lattice.
Table 1 composition of the composites investigated
Sample PP  
(wt%)
CNF  
(wt%)
HANR 
(wt%)
PP/0.5% cNF 99.5 0.5 0
PP/1% cNF 99 1 0
PP/2% cNF 98 2 0
PP/20% haNr 80 0 20
PP/0.5% cNF–20% haNr 79.5 0.5 20
PP/1% cNF–20% haNr 79 1 20
PP/2% cNF–20% haNr 78 2 20
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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Figure 2 shows the FTIR spectra of PP and HANR and 
their composites. The absorption bands of the PO
4
3− group 
of HANR (trace V) appear at 963 and 470 cm−1 (γ
1
 and γ
2
 
 vibration mode), 1,034 and 1,092 cm−1 (γ
3
 mode of P–O sym-
metric stretching vibration), and 565 and 601 cm−1 (γ
4
 P–O 
bending vibration).38 The peaks at 3,569 and 631 cm−1 are 
attributed to the hydroxide (OH−) stretching mode. The 
spectra of the PP/20% HANR and PP/1% CNF–20% HANR 
nanocomposites reveal the presence of HANR with its 
phosphate-group peaks at ∼1,050, 565, and 601 cm−1, and 
the hydroxide-group band at 3,659 cm−1.
Figure 3 is a typical SEM image of CNFs showing a 
straight-rod morphology. Such CNFs supplied by Nanostruc-
tured and Amorphous Materials are used as the reinforcement 
material for PP to form composites. Figure 4A is the SEM 
image of PP/20% HANR composite. Some HANR agglom-
erates can be observed due to its higher filler loading. The 
HANR content of 20 wt% is needed for anchoring and sup-
porting the growth of osteoblasts. For the PP/0.5% CNF–20% 
HANR and PP/2% CNF–20% HANR hybrid composites, 
CNFs with straight features disperse uniformly in the PP 
matrix (Figure 4B and C).
Thermal behavior
Figure 5 shows the thermogravimetric analysis (TGA) 
curves of pure PP, binary PP/CNF, PP/20% HANR, and 
ternary PP/CNF–HANR nanocomposites. The T
5%
 val-
ues of all the specimens are tabulated in Table 2. This 
table reveals that the T
5%
 of PP improves greatly either 
by adding 20% HANR or low CNF-loading levels. This 
demonstrates that both CNF and HANR nanofillers are 
very effective for reducing the degradation of PP at high 
temperatures. Furthermore, hybridization of CNFs with 
HANR fillers further enhances the T
5%
 value of the result-
ing composites. The PP/2% CNF–20% HANR hybrid 
nanocomposite exhibits the highest T
5%
 value of 444.6°C. 
High T
5%
 values are generally needed for biocomposites, 
10
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Figure 1 X-ray diffraction patterns of PP, haNr and their composites.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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Figure 2 (A) Fourier-transform infrared spectra of PP (i), PP/1% cNF (ii), PP/20% 
nha (iii), PP/1% cNF-20% nha (iv), and nha (v) specimens. (B) FTIr spectra of 
these specimens from 450 to 1,650 cm–1. 
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod; FTIr, fourier transform infrared. Figure 3 Scanning electron microscopy image of carbon nanofibers.
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since artificial implants are subjected to sterilization in the 
surgical operation.
Figure 6 shows the DSC cooling traces of PP, 
PP/20% HANR, PP/CNF, and PP/CNF–HANR  samples. 
The onset crystallization temperature (To),  peak 
 crystallization (Tc) temperature, and the crystallization 
enthalpy (∆Hc) are also listed in Table 2. The degree of 
crystallinity (Χc) of PP and its nanocomposites can be 
determined from:
 
Xc
Hc
f Hm
(%)
( )
=
−
100
1
∆
∆
 (1)
where ∆Hm is the melting enthalpy of the 100% crystalline 
PP, ie, 209 J/g,39,40 and f is the weight fraction of the filler of 
the nanocomposites. For pure PP, f=0. The DSC parameters 
of the aforementioned specimens are tabulated in Table 2. 
Apparently, DSC results clearly demonstrate that the HANR 
and CNF additions influence crystallization of PP greatly. 
Both the To and Tc values of PP increase considerably with 
the inclusion of CNF and/or HANR nanofillers. The To value 
of pure PP is 115.1°C, and rises to 123.9°C by adding 20 wt% 
HANR. The Tc value of PP/20% HANR nanocomposite can 
be further increased to 125.5°C by adding 2 wt% CNFs. 
The Xc value of PP is almost unchanged by adding 20 wt% 
HANR. However, the additions of 0.5–2 wt% CNFs to the 
A
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CityU1 µm
WD 9.9 mm
×10,000 5.0 kV SEI SEM
CityU1 µm
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×10,000 5.0 kV SEI SEM
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B
C
Figure 4 scanning electron micrographs of PP/20% haNr (A), PP/0.5% 
cNF–20% haNr (B), and PP/2% cNF–20% haNr (C) composites. White arrows 
indicate cNFs.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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Figure 5 Thermogravimetric analysis curves of PP, PP/0.5% cNF, PP/1% cNF, 
PP/2% cNF, PP/20% haNr, PP/0.5% cNF–20% haNr, PP/1% cNF–20% haNr, 
and PP/2% cNF–20% haNr specimens.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
Table 2 Thermal parameters of the samples investigated
Specimen To  
(°C)
Tc  
(°C)
ΔHc 
(J/g)
Xc 
(%)
T5% 
(°C)
PP 115.1 111.6 94.8 45.3 365.2
PP/0.5% cNF 124.4 120.9 96.5 46.4 427.1
PP/1% cNF 124.5 121.4 97.2 46.9 431.0
PP/2% cNF 124.5 121.4 95.0 46.3 436.1
PP/20% haNr 123.9 119.7 75.5 45.1 424.6
PP/0.5% cNF–20% haNr 124.5 121.1 81.4 48.9 440.1
PP/1% cNF–20% haNr 124.8 120.7 77.9 47.2 441.3
PP/2% cNF–20% haNr 125.5 121.7 78.4 48.1 444.6
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod; To, onset crystallization temperature, Tc, peak crystallization temperature; 
∆Hc, crystallization enthalpy; Xc, degree of crystallinity; T5%, temperature at 5% 
weight loss. 
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PP/20% HANR nanocomposites increase its crystallinity. 
Therefore, CNF nanofillers are effective nucleating sites for 
PP crystallites in the PP/HANR composites upon cooling 
from the melt.
Mechanical properties
Figure 7A and B show the elastic modulus and tensile strength 
versus CNF content for the PP/CNF and PP/CNF–HANR 
composite systems, respectively. The tensile properties of 
these specimens are summarized in Table 3. It is obvious that 
the stiffness of PP increases with increasing CNF content. 
Furthermore, the stiffness of PP increases markedly from 
1.36 GPa to 2.28 GPa by adding 20 wt% HANR (6.67 vol%), 
being 67.6% improvement. Higher HANR content is added 
to PP with bioinertness for anchoring and proliferation of 
osteoblasts on its surface. Hybridization of CNF with HANR 
further enhances the stiffness of PP. The PP/2% CNF–20% 
HANR hybrid exhibits a maximum stiffness value of 
2.52 GPa, an 85.2% enhancement over pure PP.
Liu and Wang investigated the tensile behavior of 
PP/10–25 vol% HA (24.5 µm) composites.41 They found that 
the Young’s modulus of PP (1.30 GPa) increases with HA 
content up to 25 vol%. The stiffness of the PP/25 vol% HA 
composite reaches 2.73 GPa. However, the tensile strength 
of PP (ie, 29.55 MPa) and elongation at fracture decrease 
markedly with increasing filler content. At 25 vol% HA, the 
tensile strength reduces to 20.16 MPa. These results clearly 
show that large HA particles of micrometer size are ineffec-
tive to improve the PP tensile strength.
From Table 3, the modulus and tensile strength of 
PP/20 wt% (6.67 vol%) HANR nanocomposite are 2.28 GPa 
and 30.2 MPa, respectively. The stiffness of this nanocomposite 
is slightly smaller than that of the PP/25 vol% HA microcom-
posite, but the tensile strength is much higher than that of 
the PP/25 vol% HA microcomposite. It should be noted that 
the filler content of the PP/6.67 vol% HANR nanocomposite 
80
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Figure 6 Differential scanning calorimetry (Dsc) cooling curves of PP, PP/0.5% 
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Table 3 Mechanical properties of PP-based composites
Sample Young’s  
modulus, 
MPa
Tensile  
strength, 
MPa
Elongation,  
%
Impact  
strength, 
kJ m−2
PP 1,360±20 30.0±0.2 .500 2.18±0.08
PP/0.5% cNF 1,548±42 31.6±0.3 .500 2.82±0.14
PP/1% cNF 1,574±33 31.8±0.2 .500 2.84±0.11
PP/2% cNF 1,630±25 31.9±0.3 .500 2.98±0.18
PP/20% haNr 2,280±40 30.2±0.2 8.7±0.9 1.53±0.06
PP/0.5%  
cNF–20% haNr
2,377±48 32.1±0.2 10.5±0.9 2.21±0.07
PP/1%  
cNF–20% haNr
2,473±47 32.6±0.2 8.7±0.8 2.30±0.12
PP/2%  
cNF–20% haNr
2,517±15 33.0±0.3 7.7±0.2 2.38±0.19
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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is nearly a quarter less than that of the PP/25 vol% HA 
microcomposite. When 2 wt% CNF is added to the PP/20 wt% 
(6.67 vol%) HANR nanocomposite, its modulus and tensile 
strength reaches 2.52 GPa and 33.0 MPa, respectively. This 
table also reveals that the elongation at break of PP (.500%) 
decreases sharply with the addition of rigid HANR. For the 
PP/20 wt% HANR, the elongation reduces to only 8.7%. In 
contrast, the addition of 0.5–2wt% CNFs to PP does not lead 
to a deterioration of its fracture elongation. The PP/CNF nano-
composites still retain high tensile ductility (.500%).
Figure 8 shows the Izod impact strength versus CNF 
content for the PP/CNF and PP/CNF–20% HANR nano-
composite systems. The Izod test results of the specimens 
investigated are listed in Table 3. Obviously, the impact 
strength of PP improves considerably as the CNF loading 
increases. However, the impact toughness of PP reduces 
markedly to 1.53 kJ m2 by adding 20 wt% HANR. The tough-
ness of the PP/20% HANR composite can be restored by 
CNF additions. The impact strength of PP/CNF–20% HANR 
containing 0.5–2 wt% CNFs ranges from 2.21 to 2.38 kJ m−2, 
higher than that of PP, having a value of 2.18 kJ m−2.
It is generally known that several mechanical fail-
ure modes, such as fiber breakage, crack bridging, crack 
deflection, and fiber pullout will take place in polymer 
composites filled with short fibers. In general, crack bridg-
ing contributes to an enhancement in the toughness of such 
microcomposites greatly. During mechanical deformation, 
the propagating crack is bridged by the fibers that are not 
fractured completely and capable of load-bearing activity. 
Apparently, CNFs with large aspect ratios can behave as 
carbon short fibers that bridge the grown cracks, leading 
to enhanced tensile elongation and impact strength of the 
PP/CNF and PP/CNF–20% HANR nanocomposite systems, 
as shown in Figure 8 and Table 3.
From these results, it appears that the CNF additions 
are beneficial for enhancing tensile modulus and tensile 
strength of the PP/20% HANR composite (Figure 7A and B). 
Moreover, CNF additions do not degrade tensile elonga-
tion or impact toughness of the PP/CNF–20% HANR 
 nanocomposite system, but rather improve them. The 
mechanical properties of the hybrid composites are closely 
related to their microstructural features, especially the dis-
persion of nanofillers. Microstructural examination of the 
hybrid composites reveals that straight CNFs are dispersed 
homogeneously in the polymer matrix (Figure 4B and C). 
In other words, CNFs do not cluster into agglomerates that 
degrade mechanical performance of the composites. On the 
contrary, CNTs are well known to disperse nonuniformly in 
the polymer composites. Accordingly, uniformly dispersed 
CNFs can carry applied loads effectively during tensile tests, 
leading to enhanced tensile properties of the PP/CNF–20% 
HANR nanocomposite system.
cell cultivation and viability
Figure 9A and B are respective SEM images of pure PP cul-
tivated with osteoblasts for 2 and 4 days. Very few cells are 
anchored on PP, as expected due to its bioinertness. By adding 
CNFs to PP, the number of anchored cells increases (Figures 
10 and 11), particularly for the PP/2% CNF nanocomposite 
cultured for 4 days (Figure 11B). This implies that CNFs serve 
as preferential regions for anchoring osteoblasts. This is due 
to the good bioactivity and biocompatibility of the CNFs.14,15 
Similarly, a large number of osteoblasts are seen to anchor on 
the PP/20% HANR composite (Figure 12), demonstrating the 
promotion effect of osteoblast adhesion by inorganic HANR 
fillers. By combining the bioactivity advantages of both CNFs 
and HANR, the cells colonize the hybrid-composite surfaces 
(Figures 13A and 14A) and spread over the whole surfaces 
after seeding for 4 days (Figures 13B and 14B). A high-
magnification view of osteoblast cells showing the anchoring 
of long filopodia to the composite surface is shown in Figure 
14C. This implies that the hybrid fillers provide sites for cell 
adhesion and proliferation.
The good bioactivity and biocompatibility of the CNFs 
are attributed to their nanoscale dimensions. The size of 
CNFs resembles the dimension of collagen fibrils and 
protein components of human bones. Price at al investi-
gated the effects of dimension, surface energy, and chem-
istry of carbon fibers on selective bone cell adhesion.20 
0.0
1.5
2.0
2.5
Iz
o
d
 im
p
ac
t 
st
re
n
g
th
 (
kJ
 m
−2
)
3.0
3.5
0.5 1.0
CNF content (wt%)
1.5 2.0
PP/CNF
PP/CNF–20% HANR
Figure 8 Impact strength versus cNF content of PP/cNF and PP/cNF–20% 
haNr systems.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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A
0373 10 KV ×500 WD1410 µm 0053 10 KV ×500 WD1210 µm
B
Figure 9 scanning electron micrographs of cultured osteoblasts on pure PP for 2 days (A) and 4 days (B).
Abbreviation: PP, polypropylene; KV, kilo volt; WD, working distance.
0374 10 KV ×500 WD1410 µm 0060 10 KV ×500 WD1210 µm
A B
Figure 10 scanning electron micrographs of cultured osteoblasts on PP/0.5% cNF composite for 2 days (A) and 4 days (B).
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; KV, kilo volt; WD, working distance.
A B
0387 10 KV ×500 WD1510 µm 0065 10 KV ×500 WD1210 µm
Figure 11 scanning electron micrographs of cultured osteoblasts on PP/2% cNF composite for 2 days (A) and 4 days (B).
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; KV, kilo volt; WD, working distance.
A B
0392 10 KV ×500 WD1510 µm 0066 10 KV ×500 WD1210 µm
Figure 12 scanning electron micrographs of cultured osteoblasts on PP/20% haNr composite for 2 days (A) and 4 days (B).
Abbreviations: PP, polypropylene; haNr, hydroxyapatite nanorod; KV, kilo volt; WD, working distance.
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A B
0388 10 KV ×500 WD1510 µm 0070 10 KV ×500 WD1210 µm
Figure 13 scanning electron micrographs of cultured osteoblasts on PP/0.5% cNF–20% haNr hybrid composite for 2 days (A) and 4 days (B).
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite nanorod; KV, kilo volt; WD, working distance.
They reported that CNFs with diameters ,100 nm are 
more effective than carbon fibers with diameters .100 nm 
and other metallic alloys (Ti–6Al–4V and CoCrMo) for 
promoting osteoblast adhesion. Furthermore, CNFs with-
out pyrolytic layers having higher surface energy exhibit 
enhanced osteoblastic adhesion, but reduce the seeding 
of fibroblasts, chondrocytes, and smooth-muscle cells. As 
recognized, the adhesion of osteoblasts onto nanomateri-
als is mediated through selected protein interaction, such 
as with integrin.22 Zhang and  Webster demonstrated that 
nanomaterials with favorable cell-surface characteristics 
promote extensive protein interaction and adhesion, thereby 
stimulating bone growth.15
From the literature, attachment, adhesion, and spread-
ing in bone implants are required for osteogenic cells to 
proliferate on their surfaces.42 The MTT assay has been 
recommended by the International Standards Organization 
(ISO) for the evaluation of biocompatibility of medical 
A B
C
0399 10 KV ×500 WD1510 µm 0080 10 KV ×500 WD1210 µm
0385 10 KV ×1,300 WD1510 µm
Figure 14 scanning electron micrographs of cultured osteoblasts on PP/2% cNF–20% haNr hybrid composite for 2 days (A) and 4 days (B). (C) High magnified SE image 
showing long filopodias.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite nanorod; KV, kilo volt; WD, working distance.
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devices, ie, ISO 10993-5.43 The evaluation of cell viability 
should encompass a negative control testing the absence of 
cytotoxic effects; ISO109935-1 recommends high-density 
polyethylene.44 In this study, the well with cell suspension 
and the well without cells were employed as the positive and 
negative controls, respectively.
Cellular viability is determined from the following 
equation:
 
Cell viability
absorbance of sample cells
absorbance of con
(%) =100
trol cells




.
 
  (2)
Figure 15A shows the MTT results for pure PP, PP/20% 
HANR, PP/0.5% CNF, and PP/0.5% CNF–20% HANR 
specimens cultivated for 2, 4, 7, and 10 days. The osteo-
blast viability for the PP/2% CNF and PP/2% CNF–20% 
HANR composites with higher CNF content is shown in 
Figure 15B. From Figure 15A, the osteoblast viability on 
these samples rises with increasing cultivation period up 
to 10 days. For pure PP, the cell viability is slightly below 
30% after 4 days of culture, corresponding to  cytotoxicity 
effects. The viability of PP/0.5% CNF–20% HANR is 45% 
after 4 days and reaches 68% upon cultivation for 10 days. 
By increasing CNF content in the hybrid to 2 wt%, the 
PP/2% CNF–20% HANR composite is found to exhibit the 
highest osteoblast viability on day 10 – 78%. Therefore, 
the cell viability of PP can be improved markedly by add-
ing 2% CNF and 20% HANR fillers. The MTT results for 
all samples cultured for 4 and 10 days are summarized in 
Figure 16.
For the MTT assay, the amount of formazan crystals 
produced is directly proportional to the number of meta-
bolically active cells in the culture. However, this assay can 
yield lower cell-viability values upon cultivation with CNTs. 
Wörle-Knirsch et al exposed the human alveolar epithelial 
cell line A549 to single-walled CNTs and reported that the 
MTT assay produces considerable loss in cell viability, 
due to the MTT formazan crystals clumping together with 
CNTs. Such a lumped formazan–CNT mixture dissolves 
poorly in organic solvents, eg, propanol/HCl or acetone.45 
This interference does not affect the enzymatic reaction, but 
results from the insoluble nature of MTT formazan crystals. 
However, the salt (2-[4-iodophenyl]-3-[4-nitrophenyl]-5 
-[2,4-disulfophenyl]-2H-tetrazolium) used in the WST-1 
assay can yield a water-soluble formazan product, and thus 
no solvent extraction is needed. From the MTT results, the 
PP/2% CNF–20% HANR hybrid exhibits the highest cellular 
viability. It is considered that the interference of CNF on 
MTT test results causes a reduction in cell viability. More 
extensive investigations should be done in future to elucidate 
this issue by employing other cell-viability assays.
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Figure 15 cell viability of cultured osteoblasts on PP, PP/20% haNr, PP/20% 
haNr, PP/cNF, and PP/cNF–haNr nanocomposites. error bars represent mean 
standard deviation of five identical specimens.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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Figure 16 cell viability of cultured osteoblasts on PP and its nanocomposites.
Abbreviations: PP, polypropylene; CNF, carbon nanofiber; HANR, hydroxyapatite 
nanorod.
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Conclusion
We fabricated PP/CNF nanocomposites and PP/CNF–20% 
HANR hybrids using melt-compounding and injection-
molding processes. The influences of low CNF loadings on 
the microstructural, mechanical, and thermal properties as 
well as the cellular viability of PP were investigated. The 
results show that CNF additions improve the elastic modulus 
and tensile strength of PP without sacrificing its tensile duc-
tility and impact toughness. Further enhancement in tensile 
properties of PP can be achieved by hybridizing CNF with 
HANR fillers. The PP/2% CNF–20% HANR hybrid shows 
highest stiffness and tensile strength. TGA tests reveal that 
the thermal stability of PP improves markedly either by 
adding 20% HANR or low CNF-loading levels. The PP/2% 
CNF–20% HANR hybrid also exhibits the highest T
5%
 value 
of 444.6°C. DSC measurements indicate that CNFs act as 
effective nucleating sites for PP crystallites upon cooling 
from the melt. Finally, CNF nanofillers promote osteoblas-
tic adhesion and viability on PP. The MTT results reveal 
that the PP/2% CNF–20% HANR hybrid exhibits good 
biocompatibility for osteoblasts.
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